O75909 (CCNK_HUMAN) Homo sapiens (Human)
Cyclin-K UniProtKBInterProSTRINGInteractive Modelling
580 aa; Sequence (Fasta) ; (Isoform 2; Isoform 1; Isoform 4);
5 identical sequences: Pongo abelii: A0A6D2XS62; Theropithecus gelada: A0A8D2JWZ1; Papio anubis: A0A096NJP9; Macaca mulatta: F7DAF2; Cercocebus atys: A0A2K5N2N4
It is possible new templates exist for this target since these models were created.
Available Structures
41 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal Structure of the Human Cdk12-Cyclink Complex |
Heteromer Q9NYV4; | 100 | 1×5I1; | |||
| Structure of DDB1 bound to DS17-engaged CDK12-cyclin K |
Heteromer Q16531; Q9NYV4; | 100 | 5×GOL; 1×RQL; | |||
| Structure of DDB1 bound to DS16-engaged CDK12-cyclin K |
Heteromer Q16531; Q9NYV4; | 100 | 10×SO4; 1×RNF; | |||
| Structure of DDB1 bound to DS22-engaged CDK12-cyclin K |
Heteromer Q16531; Q9NYV4; | 100 | 5×SO4; 1×RQL; | |||
| Structure of DDB1 bound to DS18-engaged CDK12-cyclin K |
Heteromer Q16531; Q9NYV4; | 100 | 12×SO4; 1×RVQ; | |||
| Structure of DDB1 bound to SR-4835-engaged CDK12-cyclin K |
Heteromer Q16531; Q9NYV4; | 100 | 1×SO4; 1×RMF; 1×CIT; | |||
| Structure of DDB1 bound to 919278-engaged CDK12-cyclin K |
Heteromer Q16531; Q9NYV4; | 100 | 2×CIT; 1×RVH; | |||
| Structure of DDB1 bound to DS43-engaged CDK12-cyclin K |
Heteromer Q16531; Q9NYV4; | 100 | 2×CIT; 1×RQ9; | |||
| Structure of DDB1 bound to Z7-engaged CDK12-cyclin K |
Heteromer Q16531; Q9NYV4; | 100 | 10×SO4; 1×RP9; | |||
| Structure of DDB1 bound to 21195-engaged CDK12-cyclin K |
Heteromer Q16531; Q9NYV4; | 100 | 1×EDO; 1×RS5; 10×SO4; | |||
| Structure of DDB1 bound to DS61-engaged CDK12-cyclin K |
Heteromer Q16531; Q9NYV4; | 100 | 7×SO4; 1×RQ5; | |||
| Structure of DDB1 bound to Z11-engaged CDK12-cyclin K |
Heteromer Q16531; Q9NYV4; | 100 | 12×SO4; 1×RVU; | |||
| Structure of DDB1 bound to DS59-engaged CDK12-cyclin K |
Heteromer Q16531; Q9NYV4; | 100 | 5×SO4; 1×RMX; | |||
| Structure of DDB1 bound to DS15-engaged CDK12-cyclin K |
Heteromer Q16531; Q9NYV4; | 100 | 11×SO4; 1×T6X; | |||
| Structure of DDB1 bound to DS11-engaged CDK12-cyclin K |
Heteromer Q16531; Q9NYV4; | 100 | 1×EDO; 8×SO4; 1×RSU; | |||
| Structure of DDB1 bound to DS30-engaged CDK12-cyclin K |
Heteromer Q16531; Q9NYV4; | 100 | 11×SO4; 1×RWN; | |||
| Structure of DDB1 bound to DS08-engaged CDK12-cyclin K |
Heteromer Q16531; Q9NYV4; | 100 | 7×SO4; 1×RWE; | |||
| Structure of DDB1 bound to dCeMM4-engaged CDK12-cyclin K |
Heteromer Q16531; Q9NYV4; | 100 | 2×CIT; 1×RNU; | |||
| Structure of DDB1 bound to DS19-engaged CDK12-cyclin K |
Heteromer Q16531; Q9NYV4; | 100 | 1×EDO; 6×SO4; 1×RSI; | |||
| Structure of DDB1 bound to DS55-engaged CDK12-cyclin K |
Heteromer Q16531; Q9NYV4; | 100 | 2×SO4; 1×RQE; | |||
| Structure of DDB1 bound to CR8-engaged CDK12-cyclinK |
Heteromer Q16531; Q9NYV4; | 100 | 1×RC8; | |||
| Structure of DDB1 bound to DRF-053-engaged CDK12-cyclin K |
Heteromer Q16531; Q9NYV4; | 100 | 1×EDO; 7×SO4; 1×RV6; | |||
| Structure of DDB1 bound to roscovitine-engaged CDK12-cyclin K |
Heteromer Q16531; Q9NYV4; | 100 | 5×SO4; 1×RRC; | |||
| Structure of DDB1 bound to HQ461-engaged CDK12-cyclin K |
Heteromer Q16531; Q9NYV4; | 100 | 2×CIT; 1×RPW; | |||
| Structure of DDB1 bound to DS24-engaged CDK12-cyclin K |
Heteromer Q16531; Q9NYV4; | 100 | 9×SO4; 1×RLC; | |||
| Structure of DDB1 bound to DS06-engaged CDK12-cyclin K |
Heteromer Q16531; Q9NYV4; | 100 | 5×SO4; 1×RUW; | |||
| Structure of DDB1 bound to DS50-engaged CDK12-cyclin K |
Heteromer Q16531; Q9NYV4; | 100 | 7×SO4; 1×RQU; | |||
| Structure of DDB1 bound to WX3-engaged CDK12-cyclin K |
Heteromer Q16531; Q9NYV4; | 100 | 5×SO4; 1×RR9; | |||
| Structure of DDB1 bound to dCeMM3-engaged CDK12-cyclin K |
Heteromer Q16531; Q9NYV4; | 100 | 4×SO4; 1×RKO; | |||
| Structure of DDB1/Cdk12/Cyclin K with molecular glue SR-4835 |
Heteromer Q16531; Q9NYV4; | 100 | 3×RMF; | |||
| Structure of DDB1 bound to Z12-engaged CDK12-cyclin K |
Heteromer Q16531; Q9NYV4; | 100 | 12×SO4; 1×RW6; | |||
| Crystal structure of human Cdk12/Cyclin K in complex with ADP-aluminum fluoride |
Heteromer Q9NYV4; | 100 | 2×ADP; 2×AF3; 7×MG; 4×EDO; | |||
| Crystal structure of human Cdk12/Cyclin K in complex with the inhibitor BSJ-01-175 |
Heteromer Q9NYV4; | 100 | 1×UUB; | |||
| Crystal structure of human Cdk13/Cyclin K in complex with the inhibitor THZ531 |
Heteromer Q14004; | 100 | 1×5I1; | |||
| Crystal structure of human Cdk13/Cyclin K in complex with ADP-aluminum fluoride |
Heteromer Q14004; | 100 | 1×ADP; 1×AF3; 2×MG; | |||
| Crystal structure of the human CDK12-cyclin K complex bound to AMPPNP |
Heteromer Q9NYV4; | 100 | ||||
| Crystal structure of human CDK12/CyclinK in complex with an inhibitor |
Heteromer Q9NYV4; | 100 | 1×MG; 1×CJM; 2×EDO; | |||
| Crystal structure of human Cdk12/Cyclin K in complex with inhibitor SR-4835 |
Heteromer Q9NYV4; | 100 | 1×RMF; | |||
| Crystal structure of the human CDK12-cyclinK complex |
Heteromer Q9NYV4; | 100 | ||||
| Structure of CDK12/CycK in complex with a small molecule inhibitor N-(4-(1-methyl-1H-pyrazol-4-yl)p… |
Heteromer Q9NYV4; | 100 | 2×MG; 1×8M1; | |||
| Crystal structure of Cyclin K | monomer | 100 | 3×ACT; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 6ckx.2.B | monomer | 0.56 | 100.00 | |||
3 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 1 | 9fmr.1.F | monomer | 0.88 | 100.00 | |||
| Isoform 2 | 9fmr.1.F | monomer | 0.89 | 100.00 | |||
| Isoform 4 | 9fmr.1.F | monomer | 0.55 | 100.00 | |||